Insider Trading & Ownership of Kate Haviland

Location: Cambridge, MA
Summary: The estimated net worth of Kate Haviland is at least $2,636,411 dollars as of 21 Jul 2025. Kate Haviland is the Chief Executive Officer, Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $2.54M. Kate Haviland is the Director of Bicara Therapeutics Inc. and owns shares of Bicara Therapeutics Inc. (BCAX) stock worth about $98.5K.
Signature: /s/ Melissa Masse, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Kate Haviland files a new Insider Trading report.

Ownership of Kate Haviland

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
BPMC	Blueprint Medicines Corp	Chief Executive Officer, Director	$2,537,920	-$1,650,670	-39%	17 Jul 2025
BCAX	Bicara Therapeutics Inc.	Director	$98,491			09 Jun 2025
FULC	Fulcrum Therapeutics, Inc.	Director				26 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.